UBS Group AG - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 35 filers reported holding ATYR PHARMA INC in Q3 2022. The put-call ratio across all filers is 5.23 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q3 2023$6,950
+231.0%
4,399
+339.9%
0.00%
Q1 2023$2,100
-88.3%
1,000
-83.3%
0.00%
Q3 2022$18,000
+200.0%
5,975
+198.8%
0.00%
Q2 2022$6,000
-71.4%
2,000
-50.0%
0.00%
Q1 2022$21,000
+162.5%
4,000
+253.4%
0.00%
Q4 2021$8,000
-46.7%
1,132
-64.2%
0.00%
Q2 2021$15,000
+200.0%
3,164
+93.3%
0.00%
Q3 2020$5,000
-97.2%
1,637
-95.9%
0.00%
Q2 2020$178,000
+67.9%
40,049
+5.4%
0.00%
Q1 2020$106,000
+657.1%
37,999
+1002.1%
0.00%
Q4 2019$14,0003,4480.00%
Other shareholders
ATYR PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 282,420$1,511,0002.38%
Tikvah Management LLC 1,350,833$7,227,0002.31%
Stonepine Capital Management, LLC 601,580$3,218,0001.34%
VR Adviser, LLC 1,398,889$7,484,0001.21%
TANG CAPITAL MANAGEMENT LLC 1,113,453$5,957,0001.19%
Deep Track Capital, LP 1,028,515$5,503,0000.35%
FEDERATED HERMES, INC. 5,222,250$27,939,0000.06%
Alyeska Investment Group, L.P. 760,798$4,070,0000.04%
Ikarian Capital, LLC 37,017$197,0000.03%
Baker Brothers Advisors 625,000$3,344,0000.02%
View complete list of ATYR PHARMA INC shareholders